Form 4 Filing for GeneDx Holdings Corp.

This filing details transactions by Leproust Emily M., a director at GeneDx Holdings Corp. On June 18, 2026, 3,576 shares of Class A Common Stock were acquired, bringing the total post-transaction shares to 24,852. Additionally, 4,248 Restricted Stock Units (RSUs) were granted, with each RSU representing a contingent right to receive one share of Class A Common Stock upon settlement. These RSUs vest based on continued service, either by the 2026 or 2027 annual meeting date or the first anniversary of the grant date. A separate transaction involved the disposal of 3,576 RSUs, resulting in 0 post-transaction shares held.